Thomas W Donner

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. doi Update on insulin therapy for type 2 diabetes
    Thomas Donner
    Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    J Clin Endocrinol Metab 97:1405-13. 2012
  2. doi Dietary supplementation with d-tagatose in subjects with type 2 diabetes leads to weight loss and raises high-density lipoprotein cholesterol
    Thomas W Donner
    Department of Internal Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    Nutr Res 30:801-6. 2010
  3. doi Cardiovascular effects of noninsulin, glucose-lowering agents: need for more outcomes data
    Parag H Joshi
    Johns Hopkins Ciccarone Center for Prevention of Heart Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Am J Cardiol 110:32B-42B. 2012
  4. doi US trends in glycemic control, treatment, and comorbidity burden in patients with diabetes
    Fadia T Shaya
    University of Maryland, School of Pharmacy, Pharmaceutical Health Services Research, 220 Arch Street, Baltimore, MD 21201, USA
    J Clin Hypertens (Greenwich) 12:826-32. 2010

Detail Information

Publications4

  1. doi Update on insulin therapy for type 2 diabetes
    Thomas Donner
    Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    J Clin Endocrinol Metab 97:1405-13. 2012
    ..A higher HbA(1c) target of 7-8% is more appropriate for patients less likely to benefit from intensive control and in those at high risk for severe hypoglycemia...
  2. doi Dietary supplementation with d-tagatose in subjects with type 2 diabetes leads to weight loss and raises high-density lipoprotein cholesterol
    Thomas W Donner
    Department of Internal Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    Nutr Res 30:801-6. 2010
    ..001). Significant improvements in body weight and high-density lipoprotein cholesterol in this pilot study suggest that d-tag may be a potentially useful adjunct in the management of patients with type 2 DM...
  3. doi Cardiovascular effects of noninsulin, glucose-lowering agents: need for more outcomes data
    Parag H Joshi
    Johns Hopkins Ciccarone Center for Prevention of Heart Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Am J Cardiol 110:32B-42B. 2012
    ....
  4. doi US trends in glycemic control, treatment, and comorbidity burden in patients with diabetes
    Fadia T Shaya
    University of Maryland, School of Pharmacy, Pharmaceutical Health Services Research, 220 Arch Street, Baltimore, MD 21201, USA
    J Clin Hypertens (Greenwich) 12:826-32. 2010
    ..The results indicate a high percentage of poor glycemic control among persons with diabetes. There were also a substantial number of comorbid conditions associated with diabetes...